Country should focus on nuclear power and carbon capture technologies, former chief scientific adviser said in his final interview (theguardian.com)
Patrick Vallance, president of research and development at the pharmaceutical giant GlaxoSmithKline, has been appointed as chief scientific adviser, the UK government announced on 8 November. (scientificamerican.com)
Signatories of the letter include David King and Robert May, former government chief scientific advisers; Colin Blakemore, a member of the U.K. Drug Policy Commission and former director of the Medical Research Council; and Gabriel Horn, chair of the Academy of Medical Sciences Working Group on Brain Science, Addiction and Drugs. (sciencemag.org)